{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:19:57Z","timestamp":1792192797267,"version":"4.4.0"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003331","name":"Provincial Health Services Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2018.00203","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:57:00Z","timestamp":1522817820000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":67,"title":["Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Jessica W. Y.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric M.","family":"Procyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall F.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair M.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","volume":"93","year":"1996","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00004714-200102000-00003","article-title":"Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine","volume":"21","author":"Agelink","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000026512","article-title":"Cardiovascular autonomic reactivity in schizophrenics under neuroleptic treatment: a potential predictor of short-term outcome?","volume":"38","author":"Agelink","year":"1998","journal-title":"Neuropsychobiology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4314\/ajpsy.v14i5.9","article-title":"Pseudophaeochromocytoma associated with clozapine therapy: a case report","volume":"14","author":"Akinsola","year":"2011","journal-title":"Afr. J. Psychiatry (Johannesbg)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1126\/science.6166045","article-title":"Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control","volume":"213","author":"Akselrod","year":"1981","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2015.02.028","article-title":"Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum","volume":"591","author":"Andreazza","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-244X-6-8","article-title":"Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia","volume":"6","author":"Ascher-Svanum","year":"2006","journal-title":"BMC Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00034","article-title":"Clozapine-associated neuroleptic malignant syndrome","volume":"137","author":"Baciewicz","year":"2002","journal-title":"Ann. Inter. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/schbul\/sbp024","article-title":"Autonomic dysfunction in unaffected first-degree relatives of patients suffering from schizophrenia","volume":"36","author":"B\u00e4r","year":"2010","journal-title":"Schizophr. Bull."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1152\/japplphysiol.00811.2006","article-title":"Decreased baroreflex sensitivity in acute schizophrenia","volume":"102","author":"B\u00e4r","year":"2007","journal-title":"J. Appl. Physiol. (1985)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jpsychires.2004.12.007","article-title":"Loss of efferent vagal activity in acute schizophrenia","volume":"39","author":"B\u00e4r","year":"2005","journal-title":"J. Psychiatr. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.schres.2007.11.027","article-title":"Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment","volume":"100","author":"Barr","year":"2008","journal-title":"Schizophr. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2010.02.1030","article-title":"Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort","volume":"119","author":"Bobes","year":"2010","journal-title":"Schizophr. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1037\/a0031228","article-title":"Antipsychotic polypharmacy increases metabolic dysregulation in female rats","volume":"21","author":"Boyda","year":"2013","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.pnpbp.2010.04.024","article-title":"A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model","volume":"34","author":"Boyda","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npp.1994.1","article-title":"The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy","volume":"10","author":"Breier","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0893-133X(97)00073-0","article-title":"Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol","volume":"17","author":"Brown","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2165\/00002018-200023030-00004","article-title":"Cardiovascular adverse effects of antipsychotic drugs","volume":"23","author":"Buckley","year":"2000","journal-title":"Drug Saf."},{"key":"B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"B21","first-page":"28","article-title":"In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug","volume-title":"J. Clin. Psychiatry","author":"Bymaster","year":"1997"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1007\/BF00442559","article-title":"Clozapine: neuroleptic-induced EPS and tardive dyskinesia","volume":"99","author":"Casey","year":"1989","journal-title":"Psychopharmacology (Berl)."},{"key":"B23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.pnpbp.2009.05.004","article-title":"Differential pattern of heart rate variability in patients with schizophrenia","volume":"33","author":"Chang","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3371\/1935-1232.10.3.163","article-title":"A guide to the management of clozapine-related tolerability and safety concerns","volume":"10","author":"Citrome","year":"2016","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00002826-200103000-00008","article-title":"Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report","volume":"24","author":"Cohen","year":"","journal-title":"Clin. Neuropharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1192\/bjp.179.2.167","article-title":"Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication","volume":"179","author":"Cohen","year":"","journal-title":"Br. J. Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1176\/ajp.156.6.863","article-title":"Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine","volume":"156","author":"Conley","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/schbul\/10.2.204","article-title":"Psychophysiological dysfunctions in the developmental course of schizophrenic disorders","volume":"10","author":"Dawson","year":"1984","journal-title":"Schizophr. Bull."},{"key":"B30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0920-9964(01)00355-3","article-title":"What does electrodermal activity tell us about prognosis in the schizophrenia spectrum?","volume":"54","author":"Dawson","year":"2002","journal-title":"Schizophr. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/01.CIR.102.11.1239","article-title":"Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities","volume":"102","author":"Dekker","year":"2000","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1053-0770(99)90016-2","article-title":"Hypotension associated with clozapine after cardiopulmonary bypass","volume":"13","author":"Donnelly","year":"1999","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"B34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/TA.0b013e31809ed924","article-title":"Hypotension begins at 110 mm Hg: redefining \u201chypotension\u201d with data","volume":"63","author":"Eastridge","year":"2007","journal-title":"J. Trauma"},{"key":"B35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0893-133X(98)00047-5","article-title":"Mechanism of peripheral noradrenergic stimulation by clozapine","volume":"20","author":"Elman","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5694\/j.1326-5377.1997.tb140118.x","article-title":"Paradoxical hypertension associated with clozapine","volume":"166","author":"Ennis","year":"1997","journal-title":"Med. J. Aust."},{"key":"B37","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1152\/physrev.1990.70.4.963","article-title":"Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions","volume":"70","author":"Esler","year":"1990","journal-title":"Physiol. Rev."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000059.pub2","article-title":"Clozapine versus typical neuroleptic medication for schizophrenia","author":"Essali","year":"2009","journal-title":"Cochr. Datab. Syst. Rev."},{"key":"B39","first-page":"683","article-title":"Clozapine's effectiveness for patients in state hospitals: results from a randomized trial","volume":"32","author":"Essock","year":"1996","journal-title":"Psychopharmacol. Bull."},{"key":"B40","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing","year":"1982","journal-title":"Br. Med. J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0300-595X(86)80078-0","article-title":"Autonomic neuropathy: its diagnosis and prognosis","volume":"15","author":"Ewing","year":"1986","journal-title":"Clin. Endocrinol. Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00414-004-0464-1","article-title":"Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment","volume":"118","author":"Fineschi","year":"2004","journal-title":"Int. J. Legal Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/heart.87.5.415","article-title":"Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris","volume":"87","author":"Forslund","year":"2002","journal-title":"Heart"},{"key":"B44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fpsyt.2014.00105","article-title":"Improving metabolic and cardiovascular health at an early psychosis intervention program in vancouver, Canada","volume":"5","author":"Fredrikson","year":"2014","journal-title":"Front. Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/acps.12425","article-title":"Clozapine-induced myocarditis: prescribe safely but do prescribe","volume":"132","author":"Freudenreich","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"B46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1600-0447.1974.tb09706.x","article-title":"Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia","volume":"50","author":"Gerlach","year":"1974","journal-title":"Acta Psychiatr. Scand."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1161\/01.CIR.0000132482.95686.87","article-title":"Digoxin in the management of cardiovascular disorders","volume":"109","author":"Gheorghiade","year":"2004","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1524-6175.2005.04769.x","article-title":"Expanding the definition and classification of hypertension","volume":"7","author":"Giles","year":"2005","journal-title":"J. Clin. Hypertens. (Greenwich)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1161\/01.CIR.0000036015.54619.B6","article-title":"Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes","volume":"106","author":"Goldstein","year":"2002","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0165-1781(93)90016-A","article-title":"Clozapine response and plasma catecholamines and their metabolites","volume":"46","author":"Green","year":"1993","journal-title":"Psychiatry Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00002018-200730010-00005","article-title":"Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003","volume":"30","author":"Haas","year":"2007","journal-title":"Drug Saf."},{"key":"B52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","article-title":"Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study","volume":"157","author":"Henderson","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.4088\/JCP.v66n0905","article-title":"Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study","volume":"66","author":"Henderson","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"B56","first-page":"S19","article-title":"Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia","volume":"60","author":"Honer","year":"2015","journal-title":"Can. J. Psychiatry"},{"key":"B57","first-page":"433","article-title":"A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy","volume":"34","author":"Honer","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2165\/00023210-200721090-00001","article-title":"Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia","volume":"21","author":"Honer","year":"2007","journal-title":"CNS Drugs"},{"key":"B59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/JCP.0b013e3182839052","article-title":"Impact of antipsychotics and anticholinergics on autonomic modulation in patients with schizophrenia","volume":"33","author":"Huang","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.schres.2012.09.011","article-title":"Empathy in electrodermal responsive and nonresponsive patients with schizophrenia","volume":"142","author":"Ikezawa","year":"2012","journal-title":"Schizophr. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: a clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann. Clin. Psychiatry"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511541667","volume-title":"The Integrative Action of the Autonomic Nervous System: Neurobiology of Homeostasis.","author":"J\u00e4nig","year":"2006"},{"key":"B63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1053\/j.jvca.2009.09.005","article-title":"Treatment of refractory hypotension with low-dose vasopressin in a patient receiving clozapine","volume":"24","author":"John","year":"2010","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"B64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1192\/pb.38.3.140a","article-title":"Cardiovascular monitoring in patients prescribed clozapine","volume":"38","author":"Jones","year":"2014","journal-title":"Psychiatr. Bull."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/sj.bjp.0701975","article-title":"The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat","volume":"124","author":"Kalkman","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/BF00429215","article-title":"Clozapine: plasma levels and prolactin response","volume":"73","author":"Kane","year":"1981","journal-title":"Psychopharmacology (Berl)."},{"key":"B67","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"323","DOI":"10.9758\/cpn.2016.14.4.323","article-title":"Clozapine monitoring in clinical practice: beyond the mandatory requirement","volume":"14","author":"Kar","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4088\/JCP.08m04718yel","article-title":"Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study","volume":"71","author":"Kelly","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pnpbp.2003.11.007","article-title":"Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects","volume":"28","author":"Kim","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/106002809703100206","article-title":"Lactic acidosis and fatal myocardial failure due to clozapine","volume":"31","author":"Koren","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/bmj.322.7296.1213","article-title":"Drug points: pseudophaeochromocytoma syndrome associated with clozapine","volume":"322","author":"Krentz","year":"2001","journal-title":"BMJ"},{"key":"B74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJM200107193450317","article-title":"Myocarditis and cardiomyopathy associated with clozapine use in the United States","volume":"345","author":"La Grenade","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(97)11144-8","article-title":"Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators","volume":"351","author":"La Rovere","year":"1998","journal-title":"Lancet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12170-013-0321-1","article-title":"Management of medication-related cardiometabolic risk in patients with severe mental illness","volume":"7","author":"Lang","year":"2013","journal-title":"Curr. Cardiovasc. Risk Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"E67","DOI":"10.1503\/jpn.150156","article-title":"Elevated clozapine plasma concentration secondary to a urinary tract infection: proposed mechanisms","volume":"41","author":"Lee","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/106002809603000606","article-title":"Cardiomyopathy associated with clozapine","volume":"30","author":"Leo","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12028-015-0129-6","article-title":"Failure of induced hypertension for symptomatic vasospasm in the setting of clozapine therapy","volume":"23","author":"Leung","year":"2015","journal-title":"Neurocrit. Care"},{"key":"B80","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pharmthera.2012.04.003","article-title":"Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system","volume":"135","author":"Leung","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3109\/00048679709065519","article-title":"Clozapine: a mimicry of phaeochromocytoma","volume":"31","author":"Li","year":"1997","journal-title":"Aust. N.Z.J. Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1600-0447.1988.tb05164.x","article-title":"The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years","volume":"77","author":"Lindstr\u00f6m","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hup.915","article-title":"Cardiac side effects of psychiatric drugs","volume":"23","author":"Mackin","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0008-6363(96)00009-0","article-title":"Linear and non-linear analyses of heart rate variability: a minireview","volume":"31","author":"Mansier","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B86","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","article-title":"Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation","volume":"42","author":"Masuo","year":"2003","journal-title":"Hypertension"},{"key":"B87","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.biopsycho.2012.09.002","article-title":"Autonomic regulation predicts performance on Wisconsin Card Sorting Test (WCST) in adults with schizophrenia","volume":"91","author":"Mathewson","year":"2012","journal-title":"Biol. Psychol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.HYP.0000225424.13138.5d","article-title":"Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans","volume":"48","author":"Mayer","year":"2006","journal-title":"Hypertension"},{"key":"B89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4088\/JCP.v66n0614","article-title":"Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients","volume":"66","author":"Melkersson","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia\u2013the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr. Med. Res. Opin."},{"key":"B92","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"B93","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1176\/ajp.152.2.183","article-title":"Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment","volume":"152","author":"Meltzer","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1176\/appi.ajp.163.2.204","article-title":"Myocarditis during clozapine treatment","volume":"163","author":"Merrill","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/01.jcp.0000150217.51433.9f","article-title":"Adverse cardiac effects associated with clozapine","volume":"25","author":"Merrill","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00004714-200006000-00006","article-title":"Sudden death in patients receiving clozapine treatment: a preliminary investigation","volume":"20","author":"Modai","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"B97","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","article-title":"Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/da.10037","article-title":"Effects of olanzapine and clozapine upon pulse rate variability","volume":"16","author":"Mueck-Weymann","year":"2002","journal-title":"Depress. Anxiety"},{"key":"B99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"B100","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1475-097X.1988.tb00208.x","article-title":"Altered balance in the autonomic nervous system in schizophrenic patients","volume":"8","author":"Nielsen","year":"1988","journal-title":"Clin. Physiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eurpsy.2014.06.004","article-title":"Cognition and autonomic function in schizophrenia: inferior cognitive test performance in electrodermal and niacin skin flush non-responders","volume":"30","author":"Nilsson","year":"2015","journal-title":"Euro. Psychiatry"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/01.CIR.98.15.1510","article-title":"Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart)","volume":"98","author":"Nolan","year":"1998","journal-title":"Circulation"},{"key":"B103","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0301-0511(81)90008-9","article-title":"Electrodermal activity and vulnerability to schizophrenia: a review","volume":"12","author":"Ohman","year":"1981","journal-title":"Biol. Psychol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1176\/ajp.2006.163.10.1821","article-title":"Hyperlipidemia following treatment with antipsychotic medications","volume":"163","author":"Olfson","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B105","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.brainresrev.2005.02.005","article-title":"The yin and yang of cardiac autonomic control: vago-sympathetic interactions revisited","volume":"49","author":"Paton","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/0019-5545.70988","article-title":"Resolution of symptoms in neuroleptic malignant syndrome","volume":"52","author":"Pereira","year":"2010","journal-title":"Ind. J. Psychiatry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/archpsyc.1992.01820050009001","article-title":"Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine","volume":"49","author":"Pickar","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"B108","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1017\/S0790966700007941","article-title":"Pseudophaeochromocytoma associated with clozapine treatment","volume":"20","author":"Prasad","year":"2003","journal-title":"Ir. J. Psychol. Med."},{"key":"B109","first-page":"168","article-title":"Do serum lipids predict response to clozapine treatment?","volume":"34","author":"Procyshyn","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4088\/JCP.08m04912gre","article-title":"Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients","volume":"71","author":"Procyshyn","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"B111","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.mehy.2013.11.043","article-title":"Clozapine administered once versus twice daily: does it make a difference?","volume":"82","author":"Procyshyn","year":"2014","journal-title":"Med. Hypoth."},{"key":"B112","first-page":"331","article-title":"Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment","volume":"32","author":"Procyshyn","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s002130050520","article-title":"Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients","volume":"135","author":"Rechlin","year":"1998","journal-title":"Psychopharmacology (Berl)."},{"key":"B115","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0006-3223(94)90026-4","article-title":"Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine","volume":"35","author":"Rechlin","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"B116","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2165\/00044011-200222050-00008","article-title":"Reduction of suicidality in patients with schizophrenia receiving clozapine","volume":"22","author":"Reinstein","year":"2002","journal-title":"Clin. Drug Investig."},{"key":"B117","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"H2039","DOI":"10.1152\/ajpheart.2000.278.6.H2039","article-title":"Physiological time-series analysis using approximate entropy and sample entropy","volume":"278","author":"Richman","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bdi.12196","article-title":"Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial","volume":"16","author":"Romo-Nava","year":"2014","journal-title":"Bipolar Disord."},{"key":"B120","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/acps.12416","article-title":"Clozapine-induced myocarditis, a widely overlooked adverse reaction","volume":"132","author":"Ronaldson","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"B121","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/00048674.2011.572852","article-title":"A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls","volume":"45","author":"Ronaldson","year":"2011","journal-title":"Aust. N.Z.J. Psychiatry"},{"key":"B122","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4088\/JCP.09m05024yel","article-title":"Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls","volume":"71","author":"Ronaldson","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"B123","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/01.HYP.36.5.824","article-title":"Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension","volume":"36","author":"Rumantir","year":"2000","journal-title":"Hypertension"},{"key":"B124","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/schbul\/17.2.247","article-title":"Update on the clinical efficacy and side effects of clozapine","volume":"17","author":"Safferman","year":"1991","journal-title":"Schizophr. Bull."},{"key":"B125","doi-asserted-by":"publisher","first-page":"194927","DOI":"10.1155\/2013\/194927","article-title":"Clozapine use presenting with pseudopheochromocytoma in a schizophrenic patient: a case report","volume":"2013","author":"Sara","year":"2013","journal-title":"Case Rep. Endocrinol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1469-8986.2005.00300.x","article-title":"Electrodermal predictors of functional outcome and negative symptoms in schizophrenia","volume":"42","author":"Schell","year":"2005","journal-title":"Psychophysiology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/01.CIR.0000081775.72651.B6","article-title":"Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy","volume":"108","author":"Schlaich","year":"2003","journal-title":"Circulation"},{"key":"B128","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/01.HYP.0000103160.35395.9E","article-title":"Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation","volume":"43","author":"Schlaich","year":"2004","journal-title":"Hypertension"},{"key":"B129","doi-asserted-by":"publisher","first-page":"845145","DOI":"10.1155\/2014\/845145","article-title":"Treating methamphetamine-induced resistant psychosis with clozapine","volume":"2014","author":"Seddigh","year":"2014","journal-title":"Case Rep. Psychiatry"},{"key":"B130","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJM200002243420803","article-title":"Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency","volume":"342","author":"Shannon","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm"},{"key":"B132","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","article-title":"Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype","volume":"268","author":"Shen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B133","first-page":"245","article-title":"Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine","volume":"21","author":"Spivak","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/0002-8703(94)90059-0","article-title":"Heart rate variability: a measure of cardiac autonomic tone","volume":"127","author":"Stein","year":"1994","journal-title":"Am. Heart J."},{"key":"B135","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13104-015-1501-5","article-title":"White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection","volume":"8","author":"Tang","year":"2015","journal-title":"BMC Res. Notes"},{"key":"B136","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","article-title":"Plasma norepinephrine in congestive heart failure","volume":"41","author":"Thomas","year":"1978","journal-title":"Am. J. Cardiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0736-4679(03)00130-6","article-title":"Delayed recovery associated with persistent serum concentrations after clozapine overdose","volume":"25","author":"Thomas","year":"2003","journal-title":"J. Emerg. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1176\/appi.ajp.2015.15070899","article-title":"Cognition and plasma ratio of clozapine to N-desmethylclozapine in patients with clozapine-resistant schizophrenia","volume":"172","author":"Thornton","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1570159X13999150424113345","article-title":"Neuroleptic malignant syndrome: a review from a clinically oriented perspective","volume":"13","author":"Tse","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.CIR.94.11.2850","article-title":"Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study","volume":"94","author":"Tsuji","year":"1996","journal-title":"Circulation"},{"key":"B142","first-page":"167","article-title":"Arrhythmic markers and clozapine in patients with schizophrenia: effect of 10 weeks clozapine treatment on heart rate variability, late potentials and QT dispersion","volume":"18","author":"T\u00fcm\u00fckl\u00fc","year":"2008","journal-title":"Klinik Psikofarmakoloji B\u00fclteni"},{"key":"B143","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1176\/appi.ajp.2013.13020215","article-title":"Chronic benign neutropenia\/agranulocytosis associated with non-clozapine antipsychotics","volume":"170","author":"Vila-Rodriguez","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"B145","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/00001648-199711000-00014","article-title":"Mortality in current and former users of clozapine","volume":"8","author":"Walker","year":"1997","journal-title":"Epidemiology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejphar.2008.06.088","article-title":"Clozapine-induced myocarditis: role of catecholamines in a murine model","volume":"592","author":"Wang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000337459","article-title":"Influence of antipsychotic agents on heart rate variability in male WKY rats: implications for cardiovascular safety","volume":"65","author":"Wang","year":"2012","journal-title":"Neuropsychobiology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bmj.4.5892.584","article-title":"Cardiac denervation in diabetes","volume":"4","author":"Wheeler","year":"1973","journal-title":"Br. Med. J."},{"key":"B149","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00228-015-1807-1","article-title":"Treatment of clozapine-associated weight gain: a systematic review","volume":"71","author":"Whitney","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/adb.12363","article-title":"Characterization of white matter integrity deficits in cocaine-dependent individuals with substance-induced psychosis compared with non-psychotic cocaine users","volume":"22","author":"Willi","year":"","journal-title":"Addict. Biol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.schres.2016.08.001","article-title":"Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users","volume":"176","author":"Willi","year":"","journal-title":"Schizophr. Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2147\/nedt.2006.2.2.235","article-title":"Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam","volume":"2","author":"Yacoub","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B153","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/oxfordjournals.schbul.a033333","article-title":"Management of the adverse effects of clozapine","volume":"24","author":"Young","year":"1998","journal-title":"Schizophr. Bull."},{"key":"B154","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0006-3223(93)90250-H","article-title":"Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine","volume":"34","author":"Zahn","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"B155","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.HYP.0000022063.50739.60","article-title":"Norepinephrine and concentric hypertrophy in patients with end-stage renal disease","volume":"40","author":"Zoccali","year":"2002","journal-title":"Hypertension"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2018.00203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:59:39Z","timestamp":1751543979000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2018.00203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":155,"alternative-id":["10.3389\/fnins.2018.00203"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2018.00203","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"article-number":"203"}}